[
1. Battinelli EM, Marshall A, Connors JM. The role of thrombophilia in pregnancy. Thrombosis 2013; 2013: 516420.10.1155/2013/516420388075124455235
]Search in Google Scholar
[
2. Devis P, M. Knuttinen G. Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management. Cardiovasc Diagn Ther 2017; 7(Suppl 3): S309–S319.10.21037/cdt.2017.10.08577851129399535
]Search in Google Scholar
[
3. Salwa Khan, Joseph D Dickerman. Hereditary thrombophilia. Thromb J 2006; 4: 15.10.1186/1477-9560-4-15159247916968541
]Search in Google Scholar
[
4. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16(2): 153-68.10.1016/S1521-6926(03)00021-5
]Search in Google Scholar
[
5. Antovic A, Blombäck M, Bremme K, He S. The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism. Blood Coagul Fibrinolysis 2002; 13(3): 181–6.10.1097/00001721-200204000-0000211943930
]Search in Google Scholar
[
6. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004; 93(2): 259–62.10.1016/j.amjcard.2003.09.05714715365
]Search in Google Scholar
[
7. Pabinger I, Grafenhofer H, Kyrle PA. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood 2002; 100(3): 1060–62.10.1182/blood-2002-01-014912130523
]Search in Google Scholar
[
8. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 2012; 141(2 Suppl): e691S-e736S.10.1378/chest.11-2300327805422315276
]Search in Google Scholar
[
9. Coppens M, Kaandorp SP, Middeldorp S. Inherited thrombophilias. Obstet Gynecol Clin North Am 2006; 33(3): 357-74.10.1016/j.ogc.2006.05.01116962914
]Search in Google Scholar
[
10. Van Cott EM1, Soderberg BL, Laposata M. Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm. Arch Pathol Lab Med 2002; 126(5): 577-82.10.5858/2002-126-0577-APCRTF11958664
]Search in Google Scholar
[
11. Mastrolia SA, Novack L, Thachil J, Rabinovich A, Pikovsky O, Klaitman V, et al. LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia. A systematic review and metaanalysis. Thromb Haemost 2016; 116(5): 868-78.10.1160/TH16-02-016927440387
]Search in Google Scholar
[
12. Liatsikos SA, Tsikouras P, Manav B, Csorba R, von Tempelhoff GF, Galazios G. Inherited thrombophilia and reproductive disorders. J Turk Ger Gynecol Assoc 2016; 17(1): 45-50.10.5152/jtgga.2016.15212479429227026779
]Search in Google Scholar
[
13. Verdu A, Cazorla MR, Granados MA, Alonso JA, Casado LF. Basilar artery thrombosis in a child heterozygous for factor V Leiden mutation. Pediatr Neurol. 2001; 24(1): 69-71.10.1016/S0887-8994(00)00228-911182285
]Search in Google Scholar
[
14. Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetricassociated venous thromboembolism. J Thromb Thrombolysis 2016; 41: 92–128.10.1007/s11239-015-1309-0471585326780741
]Search in Google Scholar
[
15. Kocher O, Cirovic C, Malynn E, et al. Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patients. Am J Clin Pathol 2007; 127(1): 68–75.10.1309/JWL27GRGU71VP5QL17145624
]Search in Google Scholar
[
16. Sottilotta G, Oriana V, Latella C, et al. Genetic prothrombotic risk factors in women with unexplained pregnancy loss. Thrombosis Research 2006; 117(6): 681–4.10.1016/j.thromres.2005.06.00516014310
]Search in Google Scholar
[
17. Lissalde-Lavigne G, Fabbro-Peray P, Cochery- Nouvellon E, et al. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control “NOHA First” study. J Thromb Haemost 2005; 3(10): 2178–84.10.1111/j.1538-7836.2005.01581.x16194196
]Search in Google Scholar
[
18. Rodger MA, Betancourt MT, Clark P, et al. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Medicine 2010; 7(6) e1000292.10.1371/journal.pmed.1000292288598520563311
]Search in Google Scholar
[
19. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132(2): 171–96.10.1111/j.1365-2141.2005.05847.x16398652
]Search in Google Scholar
[
20. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361(9361): 901–8.10.1016/S0140-6736(03)12771-712648968
]Search in Google Scholar
[
21. Roqué H, Paidas MJ, Funai EF, Kuczynski E, Lockwood CJ. Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 2004; 91(2): 290–5.10.1160/TH03-09-059614961156
]Search in Google Scholar
[
22. Robertson L, Greer I. Thromboembolism in pregnancy. Curr Opin Obstet Gynecol 2005; 17(2): 113-6.10.1097/01.gco.0000162177.30607.5915758600
]Search in Google Scholar
[
23. Oliveira LR, Fonseca JR. Simultaneous pulmonary thromboembolism and superior mesenteric venous thrombosis associated with hyperhomocysteinemia secondary to pernicious anemia-induced vitamin B12 deficiency. Hematol Transfus Cell Ther 2018; 40(1): 79-81.10.1016/j.htct.2017.11.004600093630057976
]Search in Google Scholar
[
24. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002; 101(1): 6–14.10.1016/S0301-2115(01)00496-1
]Search in Google Scholar
